What happened with PLXS today?
No read yet
Uses news and trading volume to explain the day’s move and how it relates to the market.
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
Plexus helps companies turn complex product designs into production and supports those products after launch, rather than selling its own proprietary products. Customers pay it for work ranging from development to assembly and ongoing service. For most jobs, Plexus buys and stores components, then manufactures the finished product; for some, customers supply the materials. Orders generally specify quantities, prices and delivery requirements.
Industrial and healthcare/life-sciences customers provide most of its revenue, with aerospace and defense contributing a smaller share. Its work includes medical devices, industrial automation systems and semiconductor production equipment. A group of large customers supplies a substantial share of sales, but no single customer dominates.
The business depends on customers continuing to place orders and on components arriving in time for production. Customer agreements generally do not guarantee purchase volumes, while Plexus often funds materials before receiving payment. Medical-device work must meet U.S. Food and Drug Administration and foreign requirements; defense-related work also faces specific rules. Export restrictions can limit which technologies and products it may produce in China or supply to that market.
The risk section is the longest, dullest part of the filing. This keeps only what can really hurt you: where it hits, how hard, when it plays out.
Every company claims an edge. Each one is checked against hard numbers like margins and returns: which hold, and which line gives way first.
Benchmark Electronics competes with Plexus for customers that pay them to design and manufacture complex medical, industrial, aerospace and defense, and semiconductor-equipment products. Benchmark’s semiconductor-equipment sales are one line to watch: they rose from 23% of its sales in 2023 to 28% in 2025.
Sanmina competes with Plexus for product makers’ contracts to engineer and manufacture electronics, manage parts supplies and support products after production. Watch Sanmina’s efforts to sell several of these services within one customer program, giving customers a single supplier for work Plexus also offers.
Kimball Electronics, Inc. competes with Plexus for medical and industrial customers that pay for engineering, assembly and supply-chain services for products requiring high reliability. Its ability to combine medical-device manufacturing, reliable electronics and precision molded plastics is worth watching in those competing programs.
Flex competes with Plexus for medical-device and industrial-equipment companies’ outsourced design and manufacturing work. Flex’s Regulated Manufacturing Solutions business serves these customers, making its medical-device and industrial-automation work more relevant to this rivalry than its cloud infrastructure business.
Jabil competes with Plexus for product companies that pay outside suppliers to engineer, assemble, test and manufacture their products. Jabil can take work from product planning through assembly and delivery, overlapping with the lifecycle services Plexus sells.
Celestica’s Advanced Technology Solutions business competes with Plexus for product makers’ outsourced aerospace and defense, industrial, health-technology and capital-equipment manufacturing. Watch those ATS businesses for this rivalry, rather than Celestica’s separate cloud and communications business.
GE HealthCare pays Plexus for manufacturing services and accounted for 10.3% of Plexus’s consolidated net sales in fiscal 2023; no customer reached 10% in fiscal 2024 or 2025. GE HealthCare’s medical-device sales to hospitals, health systems and researchers are the customer business to watch for this relationship.
KEY Tronic Corp competes with Plexus for product makers’ contracts to engineer products, buy components, assemble circuit boards and manufacture finished products. Its growing revenue contribution from new customer programs is worth watching as evidence of its progress in winning outsourced manufacturing work.
Celestica, Inc. earningsCLS
Celestica’s report will show what its Advanced Technology Solutions business is seeing in the aerospace, industrial and health-technology manufacturing markets that Plexus also serves.
Read sales and profitability in Celestica’s Advanced Technology Solutions business, not its separate cloud and communications business. If both strengthen, the markets for this overlapping manufacturing work look supportive, while Celestica may also be competing effectively for programs Plexus could pursue. If both weaken, demand may be soft or Celestica’s execution may be weaker. The report is a clue about Plexus’s market and rival, not proof that Plexus won or lost an order.
Plexus Corp earningsThis company
Plexus earns revenue by designing and manufacturing complex products for customers, and this report will show whether sales across its markets are supporting margins.
Compare sales in Aerospace/Defense, Healthcare/Life Sciences and Industrial with gross margin. Rising sales alongside a steady or improving margin would show that customer program ramps and demand are bringing in work Plexus can fulfill profitably. Falling sales or a narrowing margin would show that weaker demand, program endings or higher costs are offsetting those gains. Together, the figures show whether growth has support from both customer work and profitability.
GE HealthCare Technologies Inc. earningsGEHC
GE HealthCare’s report will show what hospitals, health systems and researchers are buying from this Plexus customer, offering a demand clue for Plexus’s related manufacturing work.
Read the change in GE HealthCare’s medical-device sales as a signal about its customer market, not as a substitute for Plexus order data. Stronger sales would suggest firmer demand from hospitals, health systems and researchers, which could support GE HealthCare’s need for manufacturing services; weaker sales could put that work under pressure. Plexus’s revenue still depends on GE HealthCare placing orders, so device sales alone cannot confirm a change in orders.
Fed Interest Rate Decision
Interest-rate decisions matter to Plexus because higher rates can raise the cost of its variable-rate borrowing and reduce earnings.
Expected4.0%Last release4.0%
If it comes in above expectations
Higher rates could increase Plexus’s borrowing costs as its variable-rate debt reprices, leaving less earnings after interest expense.
If it comes in below expectations
Lower rates could ease interest costs on Plexus’s variable-rate borrowing, leaving more earnings after interest expense.
JOLTs Job Openings (Sep)
Job openings track employers’ unfilled positions; for Plexus, more hiring competition can raise the wages and staffing costs involved in designing, manufacturing and supporting customers’ products.
Expected7.0MLast release7.079M
If it comes in above expectations
More openings could intensify competition for workers, raising Plexus’s wages, overtime, recruiting and training costs and squeezing operating results.
If it comes in below expectations
If the reading is below the 7.0M estimate, it is below the previous 7.079M. Fewer openings could ease competition for workers, moderating Plexus’s wage and staffing-cost pressure and helping operating results.
Non Farm Payrolls (Oct)
The monthly jobs report counts jobs added or lost; for Plexus, stronger hiring demand can make it harder and costlier to staff customer-product design, manufacturing and support work.
More jobs added suggest tighter hiring conditions that may raise Plexus’s staffing costs; fewer suggest labor-market pressure may ease, though neither outcome establishes how much costs will change.
